US Broker Ratings

Sanofi (SNY) Investor Outlook: Exploring a 32.98% Potential Upside

Sanofi (SNY), a global healthcare titan based in Paris, stands at a pivotal juncture for individual investors seeking robust opportunities within the pharmaceutical sector. With a..

Encompass Health Corporation (EHC) Stock Analysis: Navigating a 21% Upside with Robust Growth Potential

Encompass Health Corporation (NYSE: EHC), a leading player in the healthcare sector, specifically in the medical care facilities industry, has been catching the eye of investors..

Cencora, Inc. (COR) Stock Analysis: Unveiling 14% Potential Upside in the Healthcare Sector

Cencora, Inc. (NYSE: COR), a leading entity in the healthcare sector, has been making waves in the medical distribution industry with its robust operational strategies and..

United Therapeutics Corporation (UTHR): Investor Outlook on a Potential 28% Upside

United Therapeutics Corporation (NASDAQ: UTHR) stands out in the healthcare sector, specifically within the specialty and generic drug manufacturing industry. With a market capitalization of $13.31..

Cardinal Health, Inc. (CAH) Stock Analysis: Exploring a 15% Upside Potential in Medical Distribution

Cardinal Health, Inc. (NYSE: CAH) stands as a titan in the healthcare sector, specifically within the medical distribution industry. With a market capitalization of $37.23 billion,..

Incyte Corporation (INCY) Stock Analysis: Exploring Growth Potential with a 5.66% Upside

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology industry, presents an intriguing opportunity for investors seeking exposure to the healthcare sector. With a market..

Agilent Technologies (A) Stock Analysis: Exploring a 20.66% Potential Upside and Strong Buy Ratings

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector, stands out in the diagnostics and research industry with a market capitalization of $32.24..

Abbott Laboratories (ABT) Stock Analysis: Exploring a Promising 11.94% Potential Upside

Abbott Laboratories (NYSE: ABT), a stalwart in the healthcare sector, continues to captivate investor interest with its robust market presence and innovative product offerings. Headquartered in..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Healthcare Giant with a 16.77% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare sector with a strong focus on diagnostics and research, presents an intriguing opportunity for investors looking..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Unlocking Growth in the Diagnostics & Research Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) has established itself as a formidable player in the healthcare sector, particularly within the diagnostics and research industry. With a market..

ResMed Inc. (RMD) Stock Analysis: A Healthcare Leader’s 25.86% ROE Signals Robust Growth Potential

ResMed Inc. (NYSE: RMD), a stalwart in the healthcare sector, stands out in the medical instruments and supplies industry with an impressive market capitalization of $40.94..

Novo Nordisk A/S (NVO) Investor Outlook: Massive 52.57% Potential Upside Amid Robust Revenue Growth

Investors eyeing the pharmaceutical sector should take a closer look at Novo Nordisk A/S (NYSE: NVO), a Denmark-based titan in the healthcare industry, with a market..

Edwards Lifesciences Corporation (EW) Stock Analysis: A 9.56% Potential Upside Amidst Strong Revenue Growth

Edwards Lifesciences Corporation (NYSE: EW), a prominent player in the healthcare sector, specifically within the medical devices industry, has long been at the forefront of innovations..

Alcon Inc. (ALC) Stock Analysis: A 20% Upside Potential in the Healthcare Sector

Alcon Inc. (ALC), a stalwart in the healthcare sector, particularly in medical instruments and supplies, has been catching the attention of investors with its solid market..

BioNTech SE (BNTX) Stock Analysis: A Biotech Titan with 27% Potential Upside

BioNTech SE (NASDAQ: BNTX), a prominent player in the biotechnology sector, has been making waves in the healthcare industry with its innovative approach to developing immunotherapies..

Alnylam Pharmaceuticals (ALNY) Stock Analysis: High Growth Potential Amidst Expanding RNAi Pipeline

Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY), a leader in the biotechnology sector, has been at the forefront of discovering and commercializing therapeutics based on ribonucleic acid interference..

BeOne Medicines Ltd. (ONC) Investor Outlook: 12.51% Potential Upside Amid Robust Revenue Growth

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves with its focus on oncology treatments. Headquartered in Basel, Switzerland, the company..

Thermo Fisher Scientific (TMO) Stock Analysis: Navigating a 19% Potential Upside Amidst Strong Buy Ratings

Thermo Fisher Scientific Inc. (NYSE: TMO), a heavyweight in the healthcare sector, continues to capture investor interest with its robust market presence and strategic developments. With..

Elevance Health, Inc. (ELV) Stock Analysis: A Strategic Look at its 35.56% Potential Upside

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare plans sector, is capturing investor attention with a considerable potential upside of 35.56%. As healthcare..

CVS Health Corporation (CVS) Stock Analysis: A 27.91% Upside Potential Amid Strong Buy Ratings

Investors looking for stability and growth in the healthcare sector might find CVS Health Corporation (NYSE: CVS) a promising option. With a market capitalization of $79.23..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds